Advertisement
Home 2022

Archives

ENDO: Fezolinetant Cuts Vasomotor Symptoms in Menopause

0

Frequency and severity of vasomotor symptoms reduced with fezolinetant versus placebo through 12 weeks

Radiographic Findings Described for Salpingography, Recanalization

0

Patent bilateral normal fallopian tubes achieved in 86.6 and 80.7 percent of patients with primary and secondary infertility, respectively

ASCO: Ramucirumab Plus Pembrolizumab Promising in NSCLC

0

In phase 2 trial, overall survival longer with combo treatment compared with investigator's choice for standard of care in advanced NSCLC

Hormonal Contraceptives Tied to Lower Suicide Attempt Risk

0

Risk lower in women with no psychiatric history and particularly those using ethinylestradiol-containing hormonal contraceptives

ASCO: Ancestry-Specific Genetic Risk Examined for TNBC

0

Magnitudes of gene-specific risks for triple-negative breast cancer similar across racial/ethnic groups

ADA: Insulin Delivery Systems Compared in Type 1 Diabetes

0

Open-source automated insulin delivery compared to sensor augmented pump therapy in adults and children with T1D

ADA: Diabetes May Quadruple Risk for Long COVID

0

Authors say review findings are limited by heterogenous definitions of long COVID in published studies

ASCO: Risk for Suicide Elevated in Cancer Patients in the U.S.

0

Standardized mortality ratio for suicide decreased from 2000 to 2016, but risk remains elevated, especially within first two years of diagnosis

ASCO: ACA Medicaid Expansion Has Increased Access to Cancer Trials

0

Proportion of SWOG trial participants who had Medicaid insurance increased by 20 percent per year after ACA Medicaid expansion

ASCO: Parental Cancer Tied to Risk for Unmet Social Needs in Children

0

Unmet social needs include family-level food insecurity, financial worry about housing costs and other monthly bills, and transportation challenges